Centessa Pharmaceuticals plc
CNTADelisted Jun 24, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847903
Centessa Pharmaceuticals plc was delisted on Jun 24, 2026; its insiders filed their last Form 4 on Jun 24, 2026; 161 institutions reported holding it in 13F filings for Q1 2026, worth $5.90B in total; Maverick Capital was the only superinvestor holding it.
13F holders, Q2 2021
Institutional positions in Centessa Pharmaceuticals plc as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 50
- +50 vs. Q1 2021
- Shares held
- 47.4M
- +47.4M vs. Q1 2021
- Total value
- $1.05B
- +$1.05B vs. Q1 2021
- New holders
- 50
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CNTA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 161 | $5.90B |
| Q4 2025 | 147 | $3.60B |
| Q3 2025 | 125 | $3.11B |
| Q2 2025 | 117 | $1.62B |
| Q1 2025 | 130 | $1.80B |
| Q4 2024 | 114 | $2.08B |
| Q3 2024 | 103 | $1.74B |
| Q2 2024 | 80 | $781.2M |
| Q1 2024 | 69 | $840.7M |
| Q4 2023 | 58 | $567.4M |
| Q3 2023 | 49 | $469.6M |
| Q2 2023 | 45 | $435.4M |
| Q1 2023 | 44 | $257.5M |
| Q4 2022 | 44 | $194.4M |
| Q3 2022 | 44 | $288.7M |
| Q2 2022 | 41 | $350.3M |
| Q1 2022 | 44 | $669.1M |
| Q4 2021 | 47 | $807.8M |
| Q3 2021 | 40 | $947.5M |
| Q2 2021 | 50 | $1.05B |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Centessa Pharmaceuticals plc; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| US Bancorp | 19 | $0 | 0.00% | +19 | New |
| Cubist Systematic Strategies, LLC | 400 | $9.00K | 0.00% | +400 | New |
| UBS Group AG | 678 | $15.0K | 0.00% | +678 | New |
| Pinz Capital Management, LP | 900 | $20.0K | 0.01% | +900 | New |
| Citigroup Inc | 1,091 | $24.0K | 0.00% | +1,091 | New |
| Tower Research Capital LLC (TRC) | 1,077 | $24.0K | 0.00% | +1,077 | New |
| JPMorgan Chase & Co | 2,090 | $47.0K | 0.00% | +2,090 | New |
| Bank of America Corp | 2,398 | $54.0K | 0.00% | +2,398 | New |
| BlackRock Inc. | 4,992 | $110.0K | 0.00% | +4,992 | New |
| Geode Capital Management, LLC | 9,513 | $211.0K | 0.00% | +9,513 | New |
| Two Sigma Investments, LP | 9,973 | $222.0K | 0.00% | +9,973 | New |
| Northern Trust Corp | 18,400 | $409.0K | 0.00% | +18,400 | New |
| Brookfield Asset Management Inc. | 18,404 | $409.0K | 0.00% | +18,404 | New |
| Ghisallo Capital Management LLC | 25,000 | $555.0K | 0.02% | +25,000 | New |
| TD Asset Management Inc | 33,252 | $686.0K | 0.00% | +33,252 | New |
| Marshall Wace North America L.P. | 34,228 | $760.0K | 0.00% | +34,228 | New |
| Squarepoint Ops LLC | 37,771 | $839.0K | 0.01% | +37,771 | New |
| Blackstone Group Inc. | 40,000 | $888.0K | 0.00% | +40,000 | New |
| Temasek Holdings (Private) Ltd | 41,680 | $926.0K | 0.00% | +41,680 | New |
| Tudor Investment Corp Et Al | 43,079 | $957.0K | 0.02% | +43,079 | New |
| BVF Inc | 58,900 | $1.31M | 0.05% | +58,900 | New |
| Caas Capital Management LP | 62,500 | $1.39M | 0.07% | +62,500 | New |
| Affinity Asset Advisors, LLC | 66,957 | $1.49M | 0.71% | +66,957 | New |
| State of Wisconsin Investment Board | 80,381 | $1.78M | 0.00% | +80,381 | New |
| Point72 Asset Management, L.P. | 100,000 | $2.22M | 0.01% | +100,000 | New |
| Monashee Investment Management LLC | 130,000 | $2.89M | 0.35% | +130,000 | New |
| Jennison Associates LLC | 300,000 | $6.66M | 0.00% | +300,000 | New |
| Ensign Peak Advisors, Inc | 350,000 | $7.77M | 0.02% | +350,000 | New |
| American Century Companies Inc | 371,504 | $8.25M | 0.01% | +371,504 | New |
| Baker Bros. Advisors LP | 400,000 | $8.88M | 0.04% | +400,000 | New |
| Citadel Advisors LLC | 456,233 | $10.1M | 0.01% | +456,233 | New |
| Avoro Capital Advisors LLC | 500,000 | $11.1M | 0.19% | +500,000 | New |
| Millennium Management LLC | 548,452 | $12.2M | 0.02% | +548,452 | New |
| EcoR1 Capital, LLC | 754,545 | $16.8M | 0.63% | +754,545 | New |
| FMR LLC | 790,000 | $17.5M | 0.00% | +790,000 | New |
| Woodline Partners LP | 822,518 | $18.3M | 0.34% | +822,518 | New |
| Boxer Capital, LLC | 904,227 | $20.1M | 0.71% | +904,227 | New |
| Franklin Resources Inc | 922,700 | $20.5M | 0.01% | +922,700 | New |
| Logos Global Management LP | 939,545 | $20.9M | 1.79% | +939,545 | New |
| Driehaus Capital Management LLC | 999,861 | $22.2M | 0.29% | +999,861 | New |
| Wellington Management Group LLP | 1,106,577 | $24.6M | 0.00% | +1,106,577 | New |
| VR Adviser, LLC | 1,127,272 | $25.0M | 3.04% | +1,127,272 | New |
| Ra Capital Management, L.P. | 1,280,300 | $28.4M | 0.46% | +1,280,300 | New |
| Cormorant Asset Management, LP | 1,427,273 | $31.1M | 1.21% | +1,427,273 | New |
| General Atlantic LLC | 1,500,000 | $33.3M | 0.24% | +1,500,000 | New |
| Samsara BioCapital, LLC | 1,537,533 | $34.1M | 4.49% | +1,537,533 | New |
| Price T Rowe Associates Inc | 2,011,073 | $43.9M | 0.00% | +2,011,073 | New |
| Vida Ventures Advisors, LLC | 3,931,818 | $87.3M | 21.90% | +3,931,818 | New |
| Janus Henderson Group PLC | 5,680,933 | $120.1M | 0.05% | +5,680,933 | New |
| Medicxi Ventures Management (Jersey) Ltd | 17,923,892 | $398.1M | 71.34% | +17,923,892 | New |